Olivier Deschaux
Overview
Explore the profile of Olivier Deschaux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Farinelli M, Deschaux O, Hugues S, Thevenet A, Garcia R
Learn Mem
. 2006 Jun;
13(3):329-34.
PMID: 16741284
It has been shown that long-term potentiation (LTP) develops in the connection between the mediodorsal thalamus (MD) and the medial prefrontal cortex (mPFC) and between the hippocampus (HPC) and the...
12.
Deschaux O, Froestl W, Gottesmann C
Eur J Pharmacol
. 2006 Mar;
535(1-3):177-81.
PMID: 16540106
This study tested the influence of CGP 36742, a both gamma-aminobutyric acid(B) (GABA(B)) and GABA(C) receptor antagonist, on sleep and waking. The compound was injected intraperitoneally at 1, 10, 30,...
13.
Kessal K, Deschaux O, Chessel A, Xu L, Moreau J, Garcia R
Neuroreport
. 2006 Feb;
17(3):319-22.
PMID: 16462605
Stress has been reported to disrupt the induction of synaptic plasticity in different fimbria target structures. The aim of the present study was to investigate whether chronic mild stress may...
14.
Hugues S, Deschaux O, Garcia R
Learn Mem
. 2004 Oct;
11(5):540-3.
PMID: 15466305
We investigated whether postextinction training infusion of PD098059, a selective inhibitor of mitogen-activated protein kinase (MAPK) activation, into the medial prefrontal cortex, would impair retention of extinction learning in rats....
15.
Kozikowski A, Johnson K, Deschaux O, Bandyopadhyay B, Araldi G, Carmona G, et al.
J Pharmacol Exp Ther
. 2003 Mar;
305(1):143-50.
PMID: 12649362
The present study investigated the pharmacological properties of a piperidine-based novel cocaine analog, namely, (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylic acid [(+)-CPCA]. Like cocaine, (+)-CPCA inhibited rat synaptosomal dopamine and norepinephrine uptake with high...